Elevance Health (ELV) Projected to Post Earnings on Thursday

Elevance Health (NYSE:ELV - Get Free Report) is expected to announce its earnings results before the market opens on Thursday, January 23rd. Analysts expect the company to announce earnings of $3.80 per share and revenue of $44,633,169.71 billion for the quarter. Investors interested in participating in the company's conference call can do so using this link.

Elevance Health (NYSE:ELV - Get Free Report) last posted its quarterly earnings results on Thursday, October 17th. The company reported $8.37 EPS for the quarter, missing the consensus estimate of $9.66 by ($1.29). The business had revenue of $44.72 billion for the quarter, compared to analysts' expectations of $43.47 billion. Elevance Health had a return on equity of 19.56% and a net margin of 3.68%. The company's revenue was up 5.3% compared to the same quarter last year. During the same period last year, the business posted $8.99 earnings per share. On average, analysts expect Elevance Health to post $33 EPS for the current fiscal year and $35 EPS for the next fiscal year.

Elevance Health Trading Down 1.2 %

Shares of ELV traded down $4.52 during mid-day trading on Thursday, reaching $384.77. The company's stock had a trading volume of 2,406,672 shares, compared to its average volume of 1,648,917. The company's fifty day moving average price is $389.68 and its two-hundred day moving average price is $468.73. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.56. Elevance Health has a 52 week low of $362.21 and a 52 week high of $567.26. The stock has a market cap of $89.24 billion, a PE ratio of 14.03, a P/E/G ratio of 1.08 and a beta of 0.84.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on ELV. StockNews.com cut Elevance Health from a "buy" rating to a "hold" rating in a report on Wednesday, December 18th. Truist Financial dropped their price objective on Elevance Health from $520.00 to $480.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Morgan Stanley lowered their price target on shares of Elevance Health from $643.00 to $551.00 and set an "overweight" rating for the company in a report on Wednesday, October 23rd. Wells Fargo & Company dropped their price target on shares of Elevance Health from $593.00 to $495.00 and set an "overweight" rating for the company in a research report on Monday, November 4th. Finally, TD Cowen decreased their price objective on shares of Elevance Health from $589.00 to $484.00 and set a "buy" rating on the stock in a research report on Monday, October 21st. One research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $536.53.

Insider Activity

In other Elevance Health news, EVP Charles Morgan Kendrick, Jr. sold 7,417 shares of the company's stock in a transaction dated Friday, October 18th. The shares were sold at an average price of $432.14, for a total value of $3,205,182.38. Following the sale, the executive vice president now owns 8,423 shares in the company, valued at approximately $3,639,915.22. This represents a 46.82 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.35% of the stock is currently owned by company insiders.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.